Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022
2022年9月16日 - 6:59PM
Further to its previous announcements, Aleafia Health Inc. (TSX:
AH, OTCQX: ALEAF) (“
Aleafia Health” or the
“
Company”) announces that the Toronto Stock
Exchange (“
TSX”) issued a decision today to extend
its delisting review period until November 29, 2022. The Company
will provide further updates as warranted.
For Investor & Media Relations:
Matthew Sale, CFO1-833-879-2533IR@AleafiaHealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
The Company is a federally licensed Canadian
cannabis company offering cannabis products in Canadian adult-use
and medical markets and in select international markets, including
Australia and Germany. The Company operates a virtual medical
cannabis clinic staffed by physicians and nurse practitioners which
provide health and wellness services across Canada.
Aleafia Health (TSX:AH.DB)
過去 株価チャート
から 12 2024 まで 1 2025
Aleafia Health (TSX:AH.DB)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Aleafia Health Inc (トロント証券取引所): 0 recent articles
その他のニュース記事